flâneur — a map of the web's best reading

Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Program

irp.nih.gov · 1,191 words · saved by 1 readers

Advances in genomic technologies have provided us with unprecedented capabilities to explore heritable factors involved in the development of neurological diseases. Neurogenetics has already revolutionized how we think about common neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. We extend these powerful genomic techniques to other neurodegenerative diseases, such as Lewy body dementia, multiple system atrophy, frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. The Neurodegenerative Diseases Research Unit (NDRU) has been established to achieve this aim. NDRU is integrated within the Laboratory of Neurogenetics, a leader in this field over the last decade. Its primary mission is to unravel molecular genetic mechanisms that cause these devastating diseases. This knowledge identifies targets for drug development. To maximize our impact, we are building on our national and international collaborations, and we leverage the

Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Program Skip to main content Search Principal Investigators Search Sonja W. Scholz, M.D., Ph.D. Senior Investigator Neurodegenerative Diseases Research Section, Neurogenetics Branch (NGB) NINDS View Site Building 35, Room 1B-205 35 Convent Drive Bethesda, MD 20892 301-496-0013 sonja.scholz@nih.gov Research Topics Advances in genomic technologies have provided us with unprecedented capabilities to explore heritable factors involved in the development of neurological diseases. Neurogenetics has already revolutionize

Explore this link on the map →

saved by

related reading